Earnings History Data for Axovant Sciences (SIOX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Axovant Sciences

Axovant Sciences Ltd. is a biopharmaceutical company which focuses on the acquisition, development and commercialization of therapeutics for the treatment of neurodegenerative disorders. Its product candidate includes RVT-101 which is in different clinical trial for the treatment of Alzheimer's disease and other forms of dementia. Axovant Sciences Ltd. is based in Hamilton, Bermuda.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
11-02-2022	PM		SIOX	Axovant Sciences	0.00	-0.35	-0.26	0.00	Sio Gene Therapies GAAP EPS of -$0.35 misses by $0.12 [2/11/2022 7:48 AM]	0.7234	-0.08 (-9.57%)	0.80	0.0 (0.01%)	0.72 - 3.60	988,925	1,460,000	8,576
Sio Gene Therapies GAAP EPS of -$0.35 misses by $0.12 [2/11/2022 7:48 AM] Sio Gene Therapies Announces Corporate Updates and Fiscal Third Quarter 2021 Financial Results [Feb-11-22 07:00AM]
12-11-2021	PM	7:00 AM ET (Nov 12)	SIOX	Axovant Sciences	0.00	-0.29	-0.16	0.00		2.00	-0.01 (-0.75%)	1.91	-0.10 (-4.98%)	1.76 - 4.15	1,148,634	670,000	11,926
Sio Gene Therapies Announces Corporate Updates and Fiscal Second Quarter 2021 Financial Results [Nov-12-21 07:00AM] Sio Gene Therapies Announces Successful Manufacture of Three GMP Batches of AXO-Lenti-PD Gene Therapy for Parkinsons Disease [Nov-11-21 07:00AM] We're Hopeful That Sio Gene Therapies (NASDAQ:SIOX) Will Use Its Cash Wisely [Nov-12-21 10:36AM]
12-08-2021	PM		SIOX	Axovant Sciences Ltd.	0.00	-0.16	-0.18	0.00	Sio Gene Therapies EPS in-line [8/12/2021 7:45 AM]	2.04	0.09 (4.62%)	2.00	0.05 (2.56%)	1.86 - 5.74	514,981	580,000	1,073
Sio Gene Therapies EPS in-line [8/12/2021 7:45 AM] Sio Gene Therapies Announces Corporate Updates and Fiscal First Quarter 2021 Financial Results [Aug-12-21 07:00AM]
09-06-2021	PM		SIOX	Axovant Sciences Ltd.	0.00	-0.19	-0.16	0.00	Sio Gene Therapies EPS beats by $0.12 [6/9/2021 7:11 AM]	2.42	0.14 (6.14%)	2.29	0.01 (0.44%)	1.86 - 5.74	658,928	280,000	20,454
Sio Gene Therapies EPS beats by $0.12 [6/9/2021 7:11 AM] Sio Gene Therapies Announces Fiscal Year 2020 Year-End Financial Results and Expected Fiscal Year 2021 Key Milestones [Jun-09-21 07:00AM]